Mesa Laboratories, Inc.

149 articles about Mesa Laboratories, Inc.

• Mesa Labs Releases Environmental, Social, and Governance Program Brochure

  2/13/2023

  Mesa Laboratories, Inc., a global leader in the design and manufacturing of life science tools and critical quality control solutions, released its Environmental, Social, and Governance Program Brochure.

• Mesa Labs Announces Third Quarter Results

  2/6/2023

  Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacturing of life science tools and critical quality control solutions, today announced results for its third fiscal quarter (“3Q23”) ended December 31, 2022.

• Mesa Labs Declares Quarterly Dividend - Jan 03, 2023

  1/3/2023

  Mesa Laboratories, Inc. announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock.

• Mesa Laboratories, Inc. to Announce Third Quarter Results on February 6, 2023

  12/16/2022

  Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the third quarter of fiscal year 2023 at approximately 8:00 A.M. Eastern time on Monday, February 6, 2023.

• Mesa Labs Acquires Belyntic’s Peptide Purification Business

  11/17/2022

  Mesa Laboratories, Inc. announced the acquisition of substantially all of the assets and certain liabilities related to Belyntic GmbH’s peptide purification business.

• Mesa Laboratories, Inc. Appoints Shiraz Ladiwala as Lead Independent DirectorAppointment is a Key Step in Enhancing Mesa’s Corporate Governance

  11/4/2022

  Mesa Laboratories, Inc. announced that Shiraz Ladiwala has been appointed to serve as the Lead Independent Director of its Board of Directors, effective November 3, 2022.

• Mesa Labs Announces Second Quarter 2022 Results

  11/3/2022

  Mesa Laboratories, Inc. reported results for its second fiscal quarter and six months ended September 30, 2022.

• Mesa Labs Declares Quarterly Dividend - October 03, 2022

  10/3/2022

  Mesa Laboratories, Inc. announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock.

• Mesa Labs Announces First Quarter 2022 Results

  8/4/2022

  Mesa Laboratories, Inc. announced results for its first fiscal quarter.

• Mesa Labs Declares Quarterly Dividend - July 06, 2022

  7/6/2022

  Mesa Laboratories, Inc. announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock.

• Mesa Laboratories Appoints Tony Tripeny to its Board of Directors

  6/27/2022

  Mesa Laboratories, Inc. (NASDAQ:MLAB) announced the appointment of Tony Tripeny to its Board of Directors (the “Board”), effective June 23, 2022.

• Mesa Labs Reports Fourth Quarter and Full Fiscal Year Results - May 31, 2022

  5/31/2022

  Mesa Laboratories, Inc. announced results for the fourth quarter and full year ended March 31, 2022.

• Mesa Labs Declares Quarterly Dividend - Apr 06, 2022

  4/6/2022

  Mesa Laboratories, Inc. announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock.

• Mesa Labs Announces Third Quarter 2021 Results

  2/3/2022

  Mesa Laboratories, Inc. announced results for its third fiscal quarter and nine months ended December 31, 2021.

• Mesa Labs Declares Quarterly Dividend - Jan 06, 2022

  1/6/2022

  Mesa Laboratories, Inc. announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock.

• Mesa Labs Announces Second Quarter 2021 Results

  11/4/2021

  Mesa Laboratories, Inc. reported results for its second fiscal quarter and six months ended September 30, 2021.

• Leader in Corporate Development and Strategy Joins Mesa Labs Board of Directors

  10/29/2021

  Mesa Laboratories, Inc. (NASDAQ:MLAB) announced the appointment of Shiraz Ladiwala to its Board of Directors, effective October 28, 2021.

• Mesa Labs Closes Acquisition of Agena Bioscience

  10/20/2021

  Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced that it has completed the previously announced acquisition of Agena Biosciences, Inc.

• Mesa Labs Declares Quarterly Dividend - Oct 01, 2021

  10/1/2021

  Mesa Laboratories, Inc. announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock.

• Mesa Labs Announces Agreement to Acquire Agena Bioscience, Inc.

  9/14/2021

  Mesa Laboratories, Inc., a global leader in the design and manufacturing of critical quality control solutions for the pharmaceutical, healthcare, and medical device industries, announced that it has entered into a definitive agreement to acquire Agena Bioscience, Inc. for a cash purchase price of $300 million, subject to customary purchase price adjustments.